Home | Aerobe

MagPro R30

An advanced high-performance TMS magnetic stimulator designed primarily for clinical use as well as research. The MagPro R30 performs repetitive transcranial magnetic stimulation and runs many complex protocols successively; up to 20,000 pulses in one session
Liveamp

The LiveAmp is a wearable, 24-bit amplifier – available with 8, 16, 32 and also with 64 channels. As it is wireless and allows you to store your recorded data internally (i.e. on an exchangeable memory card), there are no mobility limitations.
Neurolith

Transcranial Pulse Stimulation (TPS) is a revolutionary new technique that delivers short acoustic pulses with an ultrasound frequency range. The technique allows unprecedented focal brain stimulation reaching depths of as much as 8 cm in the brain. Developed by Storz Medical, the system (NEUROLITH ®) reflects a unparalleled advancement in the field of transcranial stimulation.
NIRSport 2

The NIRSport 2 is a user-friendly, modular, and robust wireless functional near-infrared spectroscopy (fNIRS) platform which measures hemodynamic responses to neuroactivation via oxy-, deoxy-, and total hemoglobin changes in the cerebral cortex.

The NIRSport 2 comes with a host of ready-to-implement upgrades and modules to meet the needs of a broad range of cognitive neuroscience applications.
Codamotion CXS

The CXS sensor unit (CODA unit) is capable of operating in bright sunlight up to 90,000 Lux.

The CXS combines three motion sensing arrays into one unit. This allows a standalone CXS unit to make a complete 3D measurement without reference to any other units. It also means that the unit can be pre-calibrated and sealed. All the user does is to point the unit at the action.
MYOQUICK EMG

Designed with user workflow and IT standards in mind, the MYOQUICK EMG-EP system features a color coded Human Interface Device, programmable foot pedal and active handheld stimulator that maximizes efficiency and increases patient comfort.
1*1 TDCS

The Soterix Medical 1×1 was developed by clinical researchers, scientists, and biomedical engineers to provide all clinical standard tDCS protocols. Current intensity from 0.1 to 2 mA (5 mA option available upon request), and current duration from 5 to 40 minutes. Stimulation set-up is straight-forward with the simple to set-up Open-Panel™ controls, 1×1 electrode accessories, and SmartScan™ indicator. The tDCS 1×1 features allow you to focus on the subject and experiment, not the device.
Medoc Q sense

Medoc Q-Sense is a portable, easy-to-use and affordable quantitative sensory testing (QST) device for clinical, research and pharmacologic trial use.

Q-Sense offers scientifically validated measures of warm, cool and heat-pain thermal sensory thresholds. All of these can be useful determinants in the evaluation of peripheral sensory nerve function, neuropathic pain, diabetic, chemotherapeutic, and other small-fiber neuropathies.
Quest HD + Stim

The Quest HD+Stim provides extensive tES capabilities, including tDCS, tACS, tPCS and tRNS.

Extensive software APIs give you the freedom to experiment with customized and novel waveforms. Modulate experimental stimuli based on your subject’s behavioral/electrophysiological responses with the powerful on-board processing of the Quest HD+Stim.

With all of the mobility and recording features of the Quest HD, the Quest HD+Stim can perform HD tES & record HD EEG in up to 256-channel configurations.
Eyebrain T2

The EyeBrain T2 is a medical device measuring eye and head movements.

It was designed to assist in the diagnosis of neurological and psychiatric diseases and reading disorders.

Severals test are available to assess parameters as latency, speed and precision during saccads.

The EyeBrain Trackers innovate by enabling patient test results to be compared to normative values in the same way as a blood test.
MR Inroom viewing device

With its slim design, high definition 40” display and superior picture quality, the InroomViewingDevice is the optimal choice for an easy-to-use alternative to conventional projectors or goggle-based image delivery systems.
This is the ideal tool to provide images or video inside the MRI scan room.

A transdiagnostic review of safety, efficacy, and parameter space in accelerated transcranial magnetic stimulation

Repetitive transcranial magnetic stimulation (rTMS) noninvasively stimulates the brain using electromagnetic pulses, and has been FDA- approved for treatment resistant depression (TRD) (O’Reardon et al., 2007) since 2008. More recently TMS has been FDA-approved for obsessive compulsive disorder (OCD) (Carmi et al., 2019) and smoking cessation (Zangen et al., 2021), with applications to numerous other conditions under investigation. Conventional rTMS entails delivering one stimulation session per weekday for six weeks (Fig. 1) and on average among TRD samples results in 30% remission and 60% response (Carpenter et al., 2012; Sackeim et al., 2020). Although the efficacy rate in these TRD patients is clinically significant and larger than rates secondary to trying additional medications, there is clearly room for improvement in response rate and potentially speeding up response time.

22 Nov, 2022

Examining the Multisensory Contributions to Sensorimotor Control in Humans

The team at the Sensorimotor Exploration Lab at Queen’s University (Ontario, Canada), led by Dr Gerome Manson, conducts research across a wide range of areas relating to human motor control. These include: sensory contributions to motor control, motor learning, movement perception, and memory.

22 Nov, 2022

Webinar: TMS treatment of depression – an introduction

In this webinar we will provide an overview of the history as well as the basic principles of TMS. Following the introduction will be our key note speaker, Dr. Christiane Licht. This live event will be concluded with a Q&A session.

10 Nov, 2022

Micromed launched New JB EEG DSUB Jack Box

It has been designed with a new REVERSE layout to meet the requirements coming from the market where the reverse layout is required and can be used for clinical routine EEG in wireless modein combination with SD LTM PLUS amplifier.

10 Oct, 2022

New: SyncBox Scanner Interface Duo release

We are happy to announce the new SyncBox Scanner Interface Duo. The SyncBox is used to synchronize the sampling rate of the BrainAmp MR amplifier with the MR scanner clock system. In brief, the aim is to achieve phase locking between the two clock systems to facilitate optimum correction of scanner-related artifacts in the EEG data. This is essential for achieving the best EEG-fMRI data quality. The SyncBox system comprises the SyncBox Main Unit and the SyncBox Scanner Interface. The Main Unit distributes the sync signal to the BrainAmp USB 2 Adapter (BUA), which drives the sampling frequency, and also to the computer to allow online synchronization validation. Whereas, the Scanner Interface galvanically isolates the Main Unit from the MR scanner to prevent any impact on the scanner clock system.

03 Oct, 2022

Excellent test-retest repeatability for Medoc’s AlgoMed Pressure Algometer

Medoc’s AlgoMed has recently been validated in a study on patients with unilateral lateral epicondylitis. Lateral epicondylitis is a tendonitis of a lower arm muscle tendon, the extensor carpi radialis brevis muscle, at the elbow site insertion. Patients with lateral epicondylitis may suffer from functional impairment in day-to-day tasks like picking up a chair or holding a cup of coffee due to localized and radiating pain.

03 Oct, 2022

Central Neuropathic Pain in Multiple Sclerosis is Associated with Impaired Innocuous Thermal Pathway

Multiple sclerosis is a chronic disease in which inflammatory demyelinisation takes place in the central nervous system (Korn, 2008). An estimated three quarters of patients with MS suffer pain (Solaro, 2013). Pain can be secondary to other typical MS symptoms like spasticity or mood disorders, but may also be central neuropathic in its origin. Quantitative sensory testing (QST) may assist in discerning specific neural mechanisms from others. So far, there have been few pain physiology studies on MS patients, mostly using small patient cohorts and showing mixed results with QST. Some studies found that thermal sensory thresholds were impaired, which may point to damage to the STTC. This study included 153 participants: 47 MS patients with CNP, 42 pain-free MS patients, and 36 healthy controls.

03 Oct, 2022

EMTT Treatment of Ex-Professional Cyclist Marcel Wüst after Serious Cycling Accident

At this point, Marcel Wüst came to my practice and described his situation to me. I decided to treat his shoulder pain with Extracorporeal Mag-netotransduction Therapy (EMTT). Compared tonormal magnetic therapy, EMTT has a higher oscillation frequency and the magnetic field is also stronger. This allows the MAGNETOLITH® to deliver a strong »effective transduction power« of over 60 kT/s. I treated Marcel Wüst in eight ses-sions. In each case, he received 10 000 pulses at 80 mT and a frequency of 4 Hz.

30 Sep, 2022

ISMST Congress 2022 in Prague – Great Interest in TPS® and NEUROLITH®

The Czech capital of Prague hosted the 24th edition of the ISMST World Congress (International Society for Medical Shockwave Treatment). Leading scientists and physicians from around the world presented the latest in research and practice in first-class lectures and workshops on all aspects of shock wave therapy.

29 Sep, 2022

New naturalistic study shows that TMS works equally effective in all age groups

Currently, there are mixed research findings on the topic of whether advanced age is a poor prognostic indicator for rTMS. A thorough retrospective chart analysis of 495 patients between the ages of 15 and 78 was conducted to shed more light on this. At a private outpatient clinic, subjects with moderate to severe MDD had bilateral rTMS therapy (30 sessions, followed by 6–8 taper sessions).

27 Sep, 2022

Short and long-term clinical and resting-state EEG results of Transcranial Pulse Stimulation in Alzheimer’s Disease

Transcranial Pulse Stimulation (TPS) is a new non-invasive neuromodulation therapy that uses shockwaves for the treatment of Alzheimer ´ s Disease (AD). In humans, there is first evidence for beneficial clinical effects after a series of six TPS sessions. Long-term results and controlled trials are not yet reported. Experience from other centers is lacking. We report on first short-term and long-term clinical experience from a center in Germany with additional EEG recordings.

23 Sep, 2022

Transcranial Pulse Stimulation with Ultrasound in Alzheimer’s Disease—A New Navigated Focal Brain Therapy

Ultrasound-based brain stimulation techniques may become a powerful new technique to modulate the human brain in a focal and targeted manner. However, for clinical brain stimulation no certified systems exist and the current techniques have to be further developed. Here, a clinical sonication technique is introduced, based on single ultrashort ultrasound pulses (transcranial pulse stimulation, TPS) which markedly differs from existing focused ultrasound techniques.In addition, a first clinical study using ultrasound brain stimulation and first observations of long term effects are presented. Comprehensive feasibility, safety, and efficacy data are provided.

22 Sep, 2022

Examining the Multisensory Contributions to Sensorimotor Control in Humans

22 Nov, 2022

New: SyncBox Scanner Interface Duo release

03 Oct, 2022

Excellent test-retest repeatability for Medoc’s AlgoMed Pressure Algometer

03 Oct, 2022

Micromed launched New JB EEG DSUB Jack Box

10 Oct, 2022

New: SyncBox Scanner Interface Duo release

03 Oct, 2022

How to analyze a hyperscanning dataset with BrainVision Analyzer 2

Hyperscanning research has been developed to study the brain in a social environment. The interactive and social nature of the human brain is largely omitted in conventional paradigms. This is a crucial limitation for research subjects such as social behavior, interpersonal coordination, interactive decision-making, or affective communication.

18 Aug, 2022

Webinar: TMS treatment of depression – an introduction

10 Nov, 2022

ISMST Congress 2022 in Prague – Great Interest in TPS® and NEUROLITH®

29 Sep, 2022

Brain Products Upcoming Conferences, Events, Webinars and Workshops: September to December 2022

Brain Products will be attending or hosting the following events from September to December 2022. Please stop by or sign up, say hello and take the opportunity to meet our team, learn more about our application solutions or discuss your research and neuroscience requirements.

30 Aug, 2022